Facilitating Access to Clinical Trials for Eligible Patients
One of the disadvantages of the clinical trial paradigm is that it, in the past, it has been difficult for patients to access these trials. There is often a disconnect between patients and study organizers which leads to lower rates of enrollment. These delays can be especially destabilizing in the oncology landscape with such time-sensitive cases.
GoMo Health, The National Foundation for Cancer Research (NFCR), and AIM-HI are partnering to streamline access to clinical trials in patients’ specific locales and all over the world in an effort to reduce the anxiety, stress, and confusion that discourages them from seeking potentially viable clinical trials. Patients will be individually nurtured through each step of the study with messages and support to help manage expectations regarding what to expect, what’s required of them, recommendations for success, and tools for empowerment to self-manage physical and psychological impact and improve outlook. It’s all a part of our guiding principles, which define our mission of providing a system of direct-delivered resources to patients in their moment of need.